Market Research Future published a research report on Global Chronic Kidney Disease Market and predicts that Global Chronic Kidney Disease Market is expected to grow at a healthy CAGR of 5.2% during the forecasted period and report include market Analysis, Scope, Share, Progress, Current Trends and forecast till 2023.
Get Free Sample PDF @ https://www.marketresearchfuture.com/sample_request/5744
Market Insights
The chronic kidney disease is characterized by the gradual loss of kidney function over the period. If left untreated, it may lead to kidney failure. Type 1 or Type 2 diabetes, high blood pressure, glomerulonephritis, interstitial nephritis, polycystic kidney disease, and others are the common indications for the chronic kidney disease. The disease can be treated through administration of drugs at the early stage and dialysis and kidney transplant at the last stage.
Key drivers for the growth of the market are increasing the prevalence of kidney diseases, increasing number of biopsy procedures, and the rising demand for new techniques for diagnosis of chronic diseases. Global Chronic Kidney Disease Market is expected to grow at a CAGR of 5.2% during the forecast period, 2018 to 2023.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) stated that the kidney disease is frequently referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. The disease is a global health burden risk factor for Cardiovascular Diseases (CVDs). It also stated that the overall prevalence of chronic kidney disease in the general population is nearly 14%.
Key Players
MRFRs report includes the analysis of market players participating in the global chronic kidney diseases competitive landscape. Top market players include
- Hoffman-La Roche Ltd.
- Abbott
- AstraZeneca
- Pfizer
- Nova Biomedical
- ARKRAY
- OPTI Medical
- AbbVie
Market Segmentation
MRFR’s report segments the global chronic kidney disease market on the basis of diagnosis, treatment, indication, and end-user. By diagnosis, the market is segmented into blood test, urine test, imaging test, and kidney biopsy. By treatment, the market is segmented into drugs, dialysis, and kidney transplant. Drugs are further sub-segmented to include ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
By indication, the market is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others. By end-user, The market is segmented into hospitals and clinics, diagnostic centers, and others. Globally, the market is divided into the Americas, Europe, Asia-Pacific & the Middle East and Africa.
Regional Analysis – Chronic Kidney Disease Market
America dominates the Chronic Kidney Disease Market owing to increasing patient population suffering from kidney diseases and increasing number of specialty care services.
In Europe, the availability of funds for research and extensive use of diagnostic devices in hospitals and diagnostic centers are the major drivers for the growth of the market.
Asia Pacific is the fastest growing market for the chronic kidney disease whose growth is attributed to a high prevalence of diabetes and other chronic diseases. Countries such as India and China are the major contributors to the growth of the market due to the increasing awareness about kidney diseases and its risk factors and the increasing number of patients undergoing dialysis and kidney transplant.
The Middle Eastern and African market is governed by the increasing demand for specialty care services and increasing focus on the quality of care provided in the hospitals. Africa exhibits a steady growth in the market.
Latest Industry News
Researchers of the Loyola Medicine and Loyola University, Chicago Stritch School of Medicine, have found that medical nutrition therapy is the most important effective way to slow the progression of kidney diseases and prevent failure of the organs.
Johnson & Johnson has recorded highly positive data from the phase III of its chronic kidney diseases study of the drug Invokana. The company plans to release details regarding findings at a scientific conference soon.
Some Brief Table Of Content
- Report Prologue
- Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
- Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
- Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
Chapter 5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
TOC Continued…
Do You Have Query? Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5744
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.